Focus
Rare Disease Investors: Angels and VC Firms
The RaiseHunt database lists 91 Rare Disease investors: 17 angel investors and 74 people at 30 firms. Most list Series A and Seed among their stages; the largest hubs are New York, Boston and Paris.
- 91
- Rare Disease investors
- 17
- Angel investors
- 74
- People at VC/PE firms
- 30
- Firms tagged
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
91 Rare Disease investors
Showing 81-91
| Investor | Location | Type | Markets | Contact | Actions |
|---|---|---|---|---|---|
NH Noelle Hutchins Principal at Omega Funds | Boston, United States | Private equityVenture capital | Healthcare | ||
VO Vincent Ossipow Partner at Omega Funds | Geneva, Switzerland | Private equityVenture capital | Healthcare | ||
SM Shailesh Maingi Managing Partner at Kineticos Disruptor Fund | Raleigh, United States | Venture capital | AIHealthcare | ||
RL Richard Lipkin Founder at Catalytic Impact Foundation | New York City, United States | Venture capital | AIHardware | ||
CI Chieze Ibeneche-Nnewihe angel investor | Boston, United States | Angel | Healthcare | ||
AP Arnaud Pradier Venture Partner at Kurma Partners | Malakoff, France | Venture capital | AIHealthcare | ||
BJ Brent Jiang Vice President at Omega Funds | Boston, United States | Private equityVenture capital | Healthcare | ||
CN Claudio Nessi Managing Director at Omega Funds | Geneva, Switzerland | Private equityVenture capital | Healthcare | ||
RW Robert Wolk Managing Partner at Catalytic Impact Foundation | New York, United States | Venture capital | AIHealthcare | ||
RB Roshawn Blunt Venture Partner at Omega Funds | San Diego, United States | Private equityVenture capital | Healthcare | ||
PT Po Ting Liu Associate at CureDuchenne Ventures | Brookline, United States | Private equity | Healthcare |
Data: RaiseHunt investor dataset · Snapshot 26 September 2026 · How this data is built · Report a correction or request removal